Startup, 1 tracked investor.
Ab2 Bio is a startup. Brouky records 1 investor associated with the company.
Develops antibody-drug conjugates (ADCs), i.e., engineered antibodies linked to cytotoxic payloads, intended as targeted therapeutics for oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.